Immunization, Hib3 in Chile
Chile: Immunization, Hib3 was 95.0% in 2024. ▬ Flat
Immunization, Hib3 in Chile, 1996–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
The most recent figure for immunization, hib3 in Chile is 95.0%, measured in 2024.
The figure is down 1.0% on the previous year and unchanged over ten years.
Over the whole period, immunization, hib3 in Chile peaked at 97.0% in 2001 and was at its lowest, 90.0%, in 1997.
That places Chile 56th out of 191 countries with data for 2024, putting it in the middle of the range.
Immunization, Hib3 in Chile, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1996 | 91.0% | — |
| 1997 | 90.0% | -1.1% |
| 1998 | 90.0% | +0.0% |
| 1999 | 95.0% | +5.6% |
| 2000 | 91.0% | -4.2% |
| 2001 | 97.0% | +6.6% |
| 2002 | 97.0% | +0.0% |
| 2003 | 96.0% | -1.0% |
| 2004 | 93.0% | -3.1% |
| 2005 | 91.0% | -2.2% |
| 2006 | 94.0% | +3.3% |
| 2007 | 96.0% | +2.1% |
| 2008 | 95.0% | -1.0% |
| 2009 | 94.0% | -1.1% |
| 2010 | 92.0% | -2.1% |
| 2011 | 94.0% | +2.2% |
| 2012 | 90.0% | -4.3% |
| 2013 | 90.0% | +0.0% |
| 2014 | 95.0% | +5.6% |
| 2015 | 96.0% | +1.1% |
| 2016 | 95.0% | -1.0% |
| 2017 | 93.0% | -2.1% |
| 2018 | 95.0% | +2.2% |
| 2019 | 96.0% | +1.1% |
| 2020 | 93.0% | -3.1% |
| 2021 | 95.0% | +2.2% |
| 2022 | 96.0% | +1.1% |
| 2023 | 96.0% | +0.0% |
| 2024 | 95.0% | -1.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 91.5% | 90.0% | 95.0% | 4 |
| 2000s | 94.4% | 91.0% | 97.0% | 10 |
| 2010s | 93.6% | 90.0% | 96.0% | 10 |
| 2020s | 95.0% | 93.0% | 96.0% | 5 |
Countries ranked near Chile
More health data for Chile
- Un projection of annual infant deaths, annual growth rate -1.71 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4062 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,755 deaths per 1,000 people (2090)
- Number of infants who die before age 1 115 deaths (2100)
- Population ages 40-44, male, annual growth rate 1.82 % change on previous year (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, per capita 0.0367 units per person (2025)
- Population ages 45-49, female, annual growth rate 0.9362 % change on previous year (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, per capita 0.0337 units per person (2025)
Frequently asked questions
- What is immunization, hib3 in Chile?
- Immunization, hib3 in Chile was 95.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Chile?
- The highest recorded value was 97.0% in 2001.
- What is the lowest immunization, hib3 recorded in Chile?
- The lowest recorded value was 90.0% in 1997.
- How does Chile rank for immunization, hib3?
- Chile ranks 56th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Chile?
- Over the last ten years it is unchanged. The long-run trend across the full record is flat.
- Where does this Chile data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 29 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.